Pharma firms accelerate regional capacity building to secure GLP-1 supply and mitigate geopolitical risks: GlobalData Read more
Armata AP-SA02 shows promise for SAB in Phase IIa trial, underscoring growing potential of phage therapy: GlobalData Read more
FDA’s curb on overseas cell processing to hit smaller cell and gene therapy companies: GlobalData Read more
Biomarker identification to address unmet needs of idiopathic pulmonary fibrosis treatment: GlobalData Read more